126 related articles for article (PubMed ID: 15086428)
1. Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia.
Piel B; Vaidya S; Lancaster D; Taj M; Pritchard-Jones K
Br J Haematol; 2004 May; 125(3):410-1; author reply 412. PubMed ID: 15086428
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.
Rawat D; Gillett PM; Devadason D; Wilson DC; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):478-9. PubMed ID: 21701407
[TBL] [Abstract][Full Text] [Related]
3. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
[TBL] [Abstract][Full Text] [Related]
4. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
Toksvang LN; Schmidt MS; Arup S; Larsen RH; Frandsen TL; Schmiegelow K; Rank CU
PLoS One; 2019; 14(5):e0212157. PubMed ID: 31125338
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
[TBL] [Abstract][Full Text] [Related]
7. [Thioguanine, pancreatotoxicity?].
Bisschop D; Germain ML; Munzer M; Trenque T
Therapie; 2001; 56(1):67-9. PubMed ID: 11322024
[No Abstract] [Full Text] [Related]
8. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experience.
Roy Moulik N; M Taj M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28233441
[TBL] [Abstract][Full Text] [Related]
10. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
[No Abstract] [Full Text] [Related]
11. Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine.
Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):351-63. PubMed ID: 11908928
[TBL] [Abstract][Full Text] [Related]
12. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
Tokimasa S; Yamato K
Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577
[No Abstract] [Full Text] [Related]
13. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
Badowska W
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
Bossi G; Larizza D; Conter V
Haematologica; 1997; 82(4):507-8. PubMed ID: 9299875
[No Abstract] [Full Text] [Related]
16. [Leukoencephalopathy induced by the treatment of acute lymphoblastic leukemia].
Valverde F; Gil C; Bernacer M; Aracil J; Vecilla C; Sarasa JL; Contra T; Martín N; López-Ibor B; López J
An Esp Pediatr; 1988 Oct; 29 Suppl 34():39-43. PubMed ID: 3214033
[No Abstract] [Full Text] [Related]
17. Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents.
Sonnemann J; Gruhn B; Wittig S; Becker S; Beck JF
Br J Haematol; 2012 Sep; 158(5):664-6. PubMed ID: 22686282
[No Abstract] [Full Text] [Related]
18. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
19. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Kitchen BJ; Balis FM; Poplack DG; O'Brien M; Craig CE; Adamson PC
Clin Cancer Res; 1997 May; 3(5):713-7. PubMed ID: 9815740
[TBL] [Abstract][Full Text] [Related]
20. Fatal skin and liver toxicity in a patient treated with clofarabine.
Johnston DL; Mandel KM
Pediatr Blood Cancer; 2008 May; 50(5):1082. PubMed ID: 17957757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
